Indivior’s Chief Accounting Officer Buys 1,500 Shares, Signaling Executive Confidence in 2026 Growth Outlook
Indivior insider buying by CFO Anderson Woodrow shows confidence in the company’s earnings growth and strong pipeline, boosting investor sentiment.
- INDIVIOR PHARMACEUTICALS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read


